HYRNUO DIN 02563444
Health Canada record
| Active ingredient(s) | SEVABERTINIB 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01EH06 SEVABERTINIB |
| Original market date | 24-Apr-2026 |
| Current status date | 24-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36802 | 2026-01-29 | New Drug Submission (NDS) |